LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
Hs 578T WZ-4-145
3.33
uM
LJP6
 0.4960 0.0463 0.3440 0.0346
Hs 578T XMD16-144
3.33
uM
LJP5
 0.2288 0.0452 -0.0065 0.0215
Hs 578T Brivanib
3.33
uM
LJP5
 0.9354 0.0014 0.9152 0.0045
Hs 578T Buparlisib
3.33
uM
LJP5
 0.1614 0.0372 -0.0965 0.0320
Hs 578T BX-912
3.33
uM
LJP5
 0.3116 0.0567 0.1033 0.0395
Hs 578T Canertinib
3.33
uM
LJP6
 0.8416 0.0215 0.7935 0.0240
Hs 578T Celastrol
3.33
uM
LJP6
 0.2037 0.0253 -0.0417 0.0162
Hs 578T CGP60474
3.33
uM
LJP5
 0.1707 0.0610 -0.0818 0.0493
Hs 578T CGP60474
3.33
uM
LJP6
 0.1451 0.0416 -0.1179 0.0416
Hs 578T CHIR-99021
3.33
uM
LJP6
 0.8953 0.0117 0.8637 0.0121
Hs 578T CP724714
3.33
uM
LJP5
 0.9332 0.0161 0.9133 0.0191
Hs 578T CP466722
3.33
uM
LJP5
 0.9776 0.0489 0.9762 0.0622
Hs 578T Crizotinib
3.33
uM
LJP5
 0.4563 0.1099 0.2992 0.1094
Hs 578T Momelotinib
3.33
uM
LJP5
 0.5086 0.0840 0.3644 0.0805
Hs 578T Dasatinib
3.33
uM
LJP5
 0.2329 0.0835 0.0018 0.0818
Hs 578T Dasatinib
3.33
uM
LJP6
 0.1987 0.0619 -0.0454 0.0568
Hs 578T Dovitinib
3.33
uM
LJP5
 0.3950 0.0580 0.2127 0.0477
Hs 578T Enzastaurin
3.33
uM
LJP5
 1.0221 0.0202 1.0268 0.0243
Hs 578T Erlotinib
3.33
uM
LJP5
 0.9263 0.0079 0.9028 0.0129
Hs 578T Foretinib
3.33
uM
LJP5
 0.3330 0.0650 0.1306 0.0668
Hs 578T R406
3.33
uM
LJP6
 0.5951 0.0461 0.4742 0.0383
Hs 578T Pictilisib
3.33
uM
LJP6
 0.4783 0.0213 0.3162 0.0364
Hs 578T Gefitinib
3.33
uM
LJP6
 0.9757 0.0064 0.9688 0.0069
Hs 578T Geldanamycin
3.33
uM
LJP5
 0.2541 0.0617 0.0273 0.0562
Hs 578T Geldanamycin
3.33
uM
LJP6
 0.2519 0.0780 0.0264 0.0736